Covered recipient · General Payments record
DANIELLA KUKIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2023–2024
$571.59
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $555.12 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $184.22 | 9 |
| Ardelyx, Inc. | $138.91 | 6 |
| Lilly USA, LLC | $82.05 | 4 |
| Merck Sharp & Dohme Corporation | $43.15 | 2 |
| Acerta Pharma LLC | $39.84 | 2 |
| Novo Nordisk AS | $26.77 | 1 |
| Exact Sciences Corporation | $23.75 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $16.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.16 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491906 | CMS |
| ABBVIE INC. | $13.33 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491908 | CMS |
| ABBVIE INC. | $14.44 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491910 | CMS |
| ABBVIE INC. | $28.23 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491912 | CMS |
| ABBVIE INC. | $30.52 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491914 | CMS |
| ABBVIE INC. | $14.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491916 | CMS |
| ABBVIE INC. | $14.71 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491918 | CMS |
| ABBVIE INC. | $25.00 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491920 | CMS |
| ABBVIE INC. | $30.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491922 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.43 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146971155 | CMS |
| Ardelyx, Inc. | $29.22 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733814 | CMS |
| Ardelyx, Inc. | $22.70 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733816 | CMS |
| Ardelyx, Inc. | $25.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733818 | CMS |
| Ardelyx, Inc. | $30.61 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733820 | CMS |
| Ardelyx, Inc. | $3.98 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733822 | CMS |
| Ardelyx, Inc. | $26.92 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146733824 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.02 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104597166 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.82 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105618537 | CMS |
| Exact Sciences Corporation | $23.75 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114743444 | CMS |
| Lilly USA, LLC | $20.35 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135624271 | CMS |
| Lilly USA, LLC | $23.45 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135562820 | CMS |
| Lilly USA, LLC | $19.60 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135608245 | CMS |
| Lilly USA, LLC | $18.65 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614090 | CMS |
| Merck Sharp & Dohme LLC | $22.55 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141844163 | CMS |
| Merck Sharp & Dohme LLC | $20.60 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141918758 | CMS |
| Novo Nordisk Inc | $26.77 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100340394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.